RE: Critical LFD factors to consider9 Feb 2021 12:29
Thanks Chiron and for the link. I think someone quoted it yesterday, the priority order is very clear and it’s not a coincidence development was switched to an AN sample. The wishlist might as well have been written with our test in mind. It all comes down to clinical performance, if it’s also outstanding then that achieves 2 things, we’re instantly in demand with the govt and we pull up the ladder behind us as no other company will be able to get close. Moonshot is predicated on the availability of a simple to use at home high performance test. If we hit that target then it’s game on and the share price will leap. The cat in the box is wheezing, so it appears to be alive...